Release Date: 13/05/16 10:55 Summary: Company Update-TV2.AX Price Sensitive: No Download Document 273.1KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%